Skip to main content
OMDA logo

OMDA · Omada Health, Inc.

Track OMDA — free
$24.04 -0.33 (-1.35%) At close · Aug 14
Market Cap
$1.47B
Shares
61.22M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$24.04 Open$24.77 Day$23.84–24.92 52W close$10.94–26.78 Avg vol 30d1.5M Short int7.6M · 12.5% float · 5.9d Short vol24% Last earningsAug 6, 2026 DataJun 2025–Aug 2026 Filing10-Q · Aug 7

Up next

Next earnings call
Nov 5, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
filed Aug 7, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +42%
      above
      Price vs 50-day avg +15%
      above
      RSI (14) 62
      neutral
      MACD trend Positive
      52-week position 83%
      mid-range
      Momentum
      relative strength
      Very Strong
      1-month return +1%
      trailing
      6-month return +115%
      trailing
      YTD return +52%
      this year
      Relative strength +101%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $21 › 200d $17 — 50d above 200d
      Institutional flow Accumulating
      +8% holders QoQ · +35 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      12.47% of float · ▼ -4.4% MoM · 5.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      151 holders — near 1-yr high, broad support
      Squeeze score 74
      high risk · 0–100
      Fundamentals
      Excellent
      Revenue growth +53%
      Y/Y
      Gross margin 66%
      expanding
      EPS growth +94%
      Y/Y
      Free cash flow $16.9M
      Balance sheet $222.0M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 60%
      annualized · 1-yr
      Max drawdown −59%
      past year
      ATR 5.2%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 6, 2026
      Revenue · year ending December 31, 2026 $334M – $340M
      Adjusted EBITDA · year ending December 31, 2026 Non-GAAP $21M – $27M
      Prior guidance period ended · from the 8-K filed Jan 12, 2026
      Preliminary, unaudited revenue · fourth quarter of 2025 $72M – $74M
      Preliminary revenue · full year 2025 $256M – $258M
      Guided vs delivered · last 1 settled
      Revenue year ending December 31, 2025
      guided $251.5M – $254.5M
      $260.21M Beat +2.8%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Buy
      0 · 3 · 3
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +42% Bullish
      Price vs 50-day avg
      +15% Bullish
      RSI (14)
      62 Neutral
      MACD trend
      Positive Bullish
      52-week position
      83% Neutral
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $21 › 200d $17 — 50d above 200d
      Institutional flow Accumulating
      +8% holders QoQ · +35 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      12.47% of float · ▼ -4.4% MoM · 5.9 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      151 holders — near 1-yr high, broad support
      Price context
      position in its 52-week range
      Range low $11 Now $24 · 83% Range high $27
      vs 200-day avg +42% vs 50-day avg +15%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Health Information Services — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      OMDA
      Omada Health, Inc.
      this stock
      $1.47B +52.3% +53.2% 12.5%
      VEEV
      Veeva Systems Inc
      $39.60B +9.2% +28.1% 43.2 4.5%
      PMDIY
      Pro Medicus Ltd./ADR
      $14.08B -18.8% 0.0%
      BTSG
      BrightSpring Health Services, Inc.
      $12.21B +64.8% +28.2% 37.4 4.2%
      TEM
      Tempus AI, Inc.
      $9.40B -11.8% +83.4% 18.4%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      151
      % held
      87.5%
      Net QoQ
      +4.1M sh
      Top holder
      Revelation Capital Manage…
      Held Float
      View
      Held by Funds
      Fund positions
      116
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      7.6M
      Days to cover
      5.9d
      Change
      -349.9K sh
      View
      Short Volume
      Short vol %
      24%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      100
      Value
      $2.3K
      As of
      Jul 2, 2026
      View
      Off-Exchange
      Off-exchange %
      43.2%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $260.2M
      Net income (FY)
      $-12.8M
      EPS diluted
      $-0.35
      View
      Filings
      SEC Filings
      Latest
      Investor Event Transcript
      Filed
      Aug 11, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $212.9K
      Shares
      8.9K
      Filed
      Aug 12, 2026
      View
      Earnings & Events
      Earnings Calls Upcoming
      Next call
      Sep 10, 2026
      Last call
      Aug 11, 2026
      View
      Investor Relations
      Upcoming events
      1
      View

      Performance

      5D 20D 120D MTD YTD
      OMDA +1.6% +1.4% +115.2% +21.2% +52.3%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +1.2% -3.0% +101.5% +17.3% +38.5%
      Key facts CIK 1611115 CUSIP 68170A108 13F (30d) 145 filings 144 filers Visit website Investor relations